Profiling of SARS-CoV-2 virus shedding, antibody neutralization, and T-cell receptor repertoires in a large, multi-center cohort of young adults with varied prior exposures
Andrew Fioré-Gartland(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), James G. Kublin(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), R. A. Koup(National Institutes of Health), Kathryn E. Stephenson(Beth Israel Deaconess Medical Center), Alex Hannah(Adaptive Biotechnologies (United States)), Nina Marie G. Garcia(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Catherine Yen(National Institutes of Health), Holly Janes(Fred Hutch Cancer Center), Audrey Pettifor(University of North Carolina at Chapel Hill), James E. Stray(Adaptive Biotechnologies (United States)), Koshlan Mayer-Blackwell(Fred Hutch Cancer Center), Jessica Andriesen(Adaptive Biotechnologies (United States)), Moni B. Neradilek(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Elizabeth R. Brown(Fred Hutch Cancer Center), April Lo(Adaptive Biotechnologies (United States)), Tracy Qi Dong(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Robin Carroll(National Institutes of Health), Leonid Serebryannyy(National Institutes of Health), Jasmine R Marcelin(University of Nebraska Medical Center), Lawrence Corey(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Bob C. Lin(National Institutes of Health)
Cited by 0
Related Papers
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
|New England Journal of Medicine|2020|1.2k
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
|New England Journal of Medicine|2016|768
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
|The Lancet|2008|708
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
|New England Journal of Medicine|2021|661